These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 8859935)
1. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935 [TBL] [Abstract][Full Text] [Related]
2. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. MacFadyen RJ; Lees KR; Reid JL Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Nussberger J; Wuerzner G; Jensen C; Brunner HR Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102 [TBL] [Abstract][Full Text] [Related]
4. Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. Reid JL; MacFadyen RJ; Squire IB; Lees KR Am J Cardiol; 1993 Jun; 71(17):57E-60E. PubMed ID: 8392282 [TBL] [Abstract][Full Text] [Related]
5. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors. Tokita Y; Oda H; Franco-Saenz R; Mulrow PJ Proc Soc Exp Biol Med; 1995 Apr; 208(4):391-6. PubMed ID: 7700888 [TBL] [Abstract][Full Text] [Related]
6. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension. van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats. DiNicolantonio R; Doyle AE J Cardiovasc Pharmacol; 1985; 7(5):937-42. PubMed ID: 2413304 [TBL] [Abstract][Full Text] [Related]
8. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group. VĂtovec J; Spinar J Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492 [TBL] [Abstract][Full Text] [Related]
9. Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure. MacFadyen RJ; Lees KR; Reid JL Br Heart J; 1993 Apr; 69(4):293-7. PubMed ID: 8387806 [TBL] [Abstract][Full Text] [Related]
10. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit. Zhuo J; Casley D; Murone C; Mendelsohn FA J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666 [TBL] [Abstract][Full Text] [Related]
11. Experience with perindopril in normal volunteers. Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899 [TBL] [Abstract][Full Text] [Related]
13. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man. Yee KM; Struthers AD Br J Clin Pharmacol; 1998 Dec; 46(6):583-8. PubMed ID: 9862248 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man. McIntyre M; MacFadyen RJ; Meredith PA; Menard J; Brunner HR; Insuasty J; Reid JL J Cardiovasc Pharmacol; 1995 Jun; 25(6):994-1000. PubMed ID: 7564347 [TBL] [Abstract][Full Text] [Related]
15. The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs. Cambridge D; Whiting MV; Butterfield LJ; Allan G Br J Pharmacol; 1992 Jun; 106(2):342-7. PubMed ID: 1356560 [TBL] [Abstract][Full Text] [Related]
16. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure. Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004 [TBL] [Abstract][Full Text] [Related]
17. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat. Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107 [TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE? Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603 [TBL] [Abstract][Full Text] [Related]
20. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects. Brown CL; Backhouse CI; Grippat JC; Santoni JP Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]